{
    "status": "ok",
    "totalResults": 284,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Forbes"
            },
            "author": "Kenneth J. Williams Jr., Contributor, \n Kenneth J. Williams Jr., Contributor\n https://www.forbes.com/sites/kennethjwilliamsjr/",
            "title": "From Diagnosis To Advocacy: Sherri Shepherd's Fight Against Diabetes With Abbott",
            "description": "Shepherd recently teamed up with Abbott Laboratories to launch Countdown at a Crossroads during National Diabetes Awareness Month.",
            "url": "https://www.forbes.com/sites/kennethjwilliamsjr/2023/11/15/from-diagnosis-to-advocacy-sherri-shepherds-fight-against-diabetes-with-abbott/",
            "urlToImage": "https://imageio.forbes.com/specials-images/imageserve/65559d83020d2c7c4caa4c3a/0x0.jpg?format=jpg&crop=960,540,x0,y265,safe&height=900&width=1600&fit=bounds",
            "publishedAt": "2023-11-16T04:47:31Z",
            "content": "Sherri Shepherd\r\nCourtesy of Sherri Shepherd\r\nSherri Shepherd has used her platform throughout her career to tell stories that many people can relate to. From award-winning roles in her illustrious a\u2026 [+3806 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Moneycontrol"
            },
            "author": "Moneycontrol News",
            "title": "Abbott India trades lower after Q2 results, CLSA downgrades stock to outperform",
            "description": "Analysts at CLSA have downgraded the stock to outperform from Buy and have raised the target price to Rs 27,500 per share.",
            "url": "https://www.moneycontrol.com/news/business/stocks/abbott-india-trades-lower-after-q2-results-clsa-downgrades-stock-to-outperform-11732041.html",
            "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/05/Medicine-770x433.jpg",
            "publishedAt": "2023-11-13T06:03:56Z",
            "content": "Shares of Abbott India fell nearly 3 percent during early trades on November 13, after the pharma major reported a 17 percent year-on-year increase in net profit in Q2FY24. The results were announced\u2026 [+1366 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Paul Tan's Automotive News"
            },
            "author": "Anthony Lim",
            "title": "Malaysia secures RM63 bil in proposed investments from US companies \u2013 Ford among those in the list",
            "description": "In recent years, Ford has had a fairly quiet presence in the local automotive scene, but expansion may be on the cards, with news that the American automaker is set to invest in the country, [\u2026]\nThe post Malaysia secures RM63 bil in proposed investments from \u2026",
            "url": "https://paultan.org/2023/11/20/malaysia-secures-rm63-bil-in-proposed-investments-from-us-companies-ford-among-those-in-the-list/",
            "urlToImage": "https://paultan.org/image/2015/06/ford-logo-e1453775075308-630x410.jpeg",
            "publishedAt": "2023-11-20T03:30:34Z",
            "content": "In recent years, Ford has had a fairly quiet presence in the local automotive scene, but expansion may be on the cards, with news that the American automaker is set to invest in the country, accordin\u2026 [+1731 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Ossiam Grows Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "Ossiam increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 63.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,216 shares of th\u2026",
            "url": "https://www.etfdailynews.com/2023/11/30/ossiam-grows-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-30T15:32:50Z",
            "content": "Ossiam increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 63.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm\u2026 [+6615 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Short Interest Update",
            "description": "Abbott Laboratories (NYSE:ABT \u2013 Get Free Report) was the target of a significant growth in short interest in November. As of November 15th, there was short interest totalling 12,080,000 shares, a growth of 22.3% from the October 31st total of 9,880,000 shares\u2026",
            "url": "https://www.etfdailynews.com/2023/12/03/abbott-laboratories-nyseabt-short-interest-update/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-03T13:56:46Z",
            "content": "Abbott Laboratories (NYSE:ABT \u2013 Get Free Report) was the target of a significant growth in short interest in November. As of November 15th, there was short interest totalling 12,080,000 shares, a gro\u2026 [+6125 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Mirova Trims Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "Mirova trimmed its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 52.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,696 shares of the healthcare produc\u2026",
            "url": "https://www.etfdailynews.com/2023/11/28/mirova-trims-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-28T20:48:44Z",
            "content": "Mirova trimmed its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 52.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The instit\u2026 [+5608 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research Nester",
            "title": "Blood Screening Market revenue to hit USD 5.03 Billion by 2035, says Research Nester",
            "description": "Key blood screening market players include Abbott Laboratories, Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho al Diagnostics, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Beckman Coulter, Inc., and others. Key \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2786755/0/en/Blood-Screening-Market-revenue-to-hit-USD-5-03-Billion-by-2035-says-Research-Nester.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/77e335b1-e272-4a4c-a0ff-211ce0caee29",
            "publishedAt": "2023-11-28T11:00:00Z",
            "content": "New York, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The global blood screening market size is poised to grow at a CAGR of over 6% from 2023 to 2035. The market is anticipated to garner a revenue of USD 5.3 b\u2026 [+6053 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research Nester",
            "title": "Lateral Flow Assays Market revenue to exceed USD 180 Billion by 2035, says Research Nester",
            "description": "Major lateral flow assays (LFA) market players include Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Merck kG\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/08/2775915/0/en/Lateral-Flow-Assays-Market-revenue-to-exceed-USD-180-Billion-by-2035-says-Research-Nester.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/77e335b1-e272-4a4c-a0ff-211ce0caee29",
            "publishedAt": "2023-11-08T10:00:00Z",
            "content": "New York, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The global lateral flow assays market size is expected to expand at ~7% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD 180 bi\u2026 [+5964 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Center for Financial Planning Inc. Boosts Position in Abbott Laboratories (NYSE:ABT)",
            "description": "Center for Financial Planning Inc. boosted its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 17,775 shares of the healthcare product maker\u2019s stock \u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/center-for-financial-planning-inc-boosts-position-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T20:10:45Z",
            "content": "Center for Financial Planning Inc. boosted its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm \u2026 [+6867 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Souders Financial Advisors Reduces Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Souders Financial Advisors lowered its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.7% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 36,421 shares of the healthcare product maker\u2019s stock after selling 1,797\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/souders-financial-advisors-reduces-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T17:06:52Z",
            "content": "Souders Financial Advisors lowered its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.7% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 36,421 shares\u2026 [+6507 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Coherent Market Insights Pvt. Ltd",
            "title": "Deep Brain Stimulation Devices Market to Hit $2,508.5 Million by 2030, Rising at 9.8% CAGR | Coherent Market Insights",
            "description": "Deep Brain Stimulation Devices Companies Analyzed are Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA. Deep Brain Stimulation Devices Companies Analyze\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/10/2778327/0/en/Deep-Brain-Stimulation-Devices-Market-to-Hit-2-508-5-Million-by-2030-Rising-at-9-8-CAGR-Coherent-Market-Insights.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/450ec960-647a-4b12-8885-a4afd6739e88",
            "publishedAt": "2023-11-10T13:35:00Z",
            "content": "Burlingame, Nov. 10, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global\u00a0deep brain stimulation device market is estimated to be valued at US$ 1,188.9 million in 2022 and is expect\u2026 [+10539 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Acadian Asset Management LLC Sells 46,977 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Acadian Asset Management LLC lowered its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 56.6% during the second quarter, Holdings Channel.com reports. The institutional investor owned 35,963 shares of the healthcare product maker\u2019s stock a\u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/acadian-asset-management-llc-sells-46977-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T14:06:54Z",
            "content": "Acadian Asset Management LLC lowered its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 56.6% during the second quarter, Holdings Channel.com reports. The institutional investor o\u2026 [+6738 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Element Capital Management LLC Raises Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "Element Capital Management LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.4% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 238,835 shares of the healthcare pro\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/element-capital-management-llc-raises-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T16:38:51Z",
            "content": "Element Capital Management LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.4% during the 2nd quarter, according to its most recent 13F filing with the SEC. The insti\u2026 [+6947 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Mystic Asset Management Inc. Sells 300 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Mystic Asset Management Inc. decreased its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.4% during the 2nd quarter, Holdings Channel reports. The firm owned 20,727 shares of the healthcare product maker\u2019s stock after selling 300 shares during \u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/mystic-asset-management-inc-sells-300-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T17:54:43Z",
            "content": "Mystic Asset Management Inc. decreased its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.4% during the 2nd quarter, Holdings Channel reports. The firm owned 20,727 shares of the healt\u2026 [+6783 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Capital International Investors Has $6.45 Billion Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Capital International Investors increased its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 59,178,607 shares of the hea\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/capital-international-investors-has-6-45-billion-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T21:24:47Z",
            "content": "Capital International Investors increased its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.9% during the second quarter, according to its most recent filing with the Securities and Exch\u2026 [+6685 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Puzo Michael J Sells 279 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Puzo Michael J trimmed its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 88,548 shares of the healthcar\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/puzo-michael-j-sells-279-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T19:37:08Z",
            "content": "Puzo Michael J trimmed its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Com\u2026 [+6390 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Fort L.P. Sells 99 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Fort L.P. cut its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 3.5% in the second quarter, HoldingsChannel reports. The institutional investor owned 2,766 shares of the healthcare product maker\u2019s stock after selling 99 shares during the quarter. F\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/fort-l-p-sells-99-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T17:06:45Z",
            "content": "Fort L.P. cut its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 3.5% in the second quarter, HoldingsChannel reports. The institutional investor owned 2,766 shares of the healthcare product\u2026 [+5923 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Holdings Reduced by Sepio Capital LP",
            "description": "Sepio Capital LP lessened its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 3.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 233,992 shares of the healthcare produ\u2026",
            "url": "https://www.etfdailynews.com/2023/11/07/abbott-laboratories-nyseabt-holdings-reduced-by-sepio-capital-lp/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-07T17:18:47Z",
            "content": "Sepio Capital LP lessened its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 3.8% in the 2nd quarter, according to the company in its most recent filing with the Securities &amp; Exchange C\u2026 [+6791 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Purchased by Nwam LLC",
            "description": "Nwam LLC lifted its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 162.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 13,304 shares of the healthcare product maker\u2019s stock after purchasing an additional 8,233 shares during the p\u2026",
            "url": "https://www.etfdailynews.com/2023/11/16/abbott-laboratories-nyseabt-shares-purchased-by-nwam-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-16T22:16:41Z",
            "content": "Nwam LLC lifted its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 162.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 13,304 shares of the healthcare product maker\u2019s st\u2026 [+5937 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Stock Position Increased by ICW Investment Advisors LLC",
            "description": "ICW Investment Advisors LLC raised its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,262 shares of the healthcare\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/abbott-laboratories-nyseabt-stock-position-increased-by-icw-investment-advisors-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T20:10:45Z",
            "content": "ICW Investment Advisors LLC raised its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchang\u2026 [+6395 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Grandfield & Dodd LLC Reduces Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Grandfield & Dodd LLC reduced its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 14,795 shares of the healthcare product maker\u2019s stock after selling 312 sha\u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/grandfield-dodd-llc-reduces-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T16:50:57Z",
            "content": "Grandfield &amp; Dodd LLC reduced its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 14,795 shar\u2026 [+6671 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Position Increased by Nvwm LLC",
            "description": "Nvwm LLC increased its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 19,822 shares of the healthcare product maker\u2019s stock after buying an additional 1\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/abbott-laboratories-nyseabt-position-increased-by-nvwm-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T19:38:43Z",
            "content": "Nvwm LLC increased its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 19,822 shares of the h\u2026 [+6316 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Diamond Hill Capital Management Inc. Sells 145,124 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Diamond Hill Capital Management Inc. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.8% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,076,281 shares of the\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/diamond-hill-capital-management-inc-sells-145124-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T19:54:52Z",
            "content": "Diamond Hill Capital Management Inc. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.8% during the 2nd quarter, according to its most recent 13F filing with the S\u2026 [+6681 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Natixis Purchases 303,070 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Natixis raised its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 71.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 729,648 shares of the healthcare prod\u2026",
            "url": "https://www.etfdailynews.com/2023/11/28/natixis-purchases-303070-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-28T18:33:03Z",
            "content": "Natixis raised its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 71.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission\u2026 [+6685 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Robertson Stephens Wealth Management LLC Sells 291 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Robertson Stephens Wealth Management LLC reduced its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.1% in the 2nd quarter, HoldingsChannel reports. The firm owned 13,560 shares of the healthcare product maker\u2019s stock after selling 291 shares du\u2026",
            "url": "https://www.etfdailynews.com/2023/11/30/robertson-stephens-wealth-management-llc-sells-291-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-30T21:14:42Z",
            "content": "Robertson Stephens Wealth Management LLC reduced its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.1% in the 2nd quarter, HoldingsChannel reports. The firm owned 13,560 shares of the \u2026 [+5843 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Commerce Bank Sells 20,405 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Commerce Bank reduced its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.7% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 747,107 shares of the healthcare product ma\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/commerce-bank-sells-20405-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T19:54:51Z",
            "content": "Commerce Bank reduced its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.7% during the second quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commis\u2026 [+6497 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Stock Position Raised by Palisade Asset Management LLC",
            "description": "Palisade Asset Management LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.3% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 207,154 shares of the healthcare \u2026",
            "url": "https://www.etfdailynews.com/2023/11/07/abbott-laboratories-nyseabt-stock-position-raised-by-palisade-asset-management-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-07T20:16:42Z",
            "content": "Palisade Asset Management LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.3% during the second quarter, according to its most recent filing with the SEC. The in\u2026 [+6108 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Somerville Kurt F Sells 19,723 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Somerville Kurt F lessened its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 11.2% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,016 shares of\u2026",
            "url": "https://www.etfdailynews.com/2023/11/29/somerville-kurt-f-sells-19723-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-29T17:58:49Z",
            "content": "Somerville Kurt F lessened its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 11.2% during the second quarter, according to its most recent Form 13F filing with the Securities &amp; Exchang\u2026 [+5896 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Wintrust Investments LLC Purchases 1,114 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Wintrust Investments LLC grew its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 25,590 shares of the healthcare product maker\u2019s stock after acquiring an\u2026",
            "url": "https://www.etfdailynews.com/2023/11/15/wintrust-investments-llc-purchases-1114-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-15T22:14:42Z",
            "content": "Wintrust Investments LLC grew its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 25,590 share\u2026 [+5721 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Diversified Portfolios Inc. Decreases Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Diversified Portfolios Inc. trimmed its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 10.0% in the second quarter, Holdings Channel.com reports. The institutional investor owned 3,583 shares of the healthcare product maker\u2019s stock after selling \u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/diversified-portfolios-inc-decreases-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T18:18:44Z",
            "content": "Diversified Portfolios Inc. trimmed its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 10.0% in the second quarter, Holdings Channel.com reports. The institutional investor owned 3,583 s\u2026 [+5863 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Roundview Capital LLC Has $925,000 Stock Position in Abbott Laboratories (NYSE:ABT)",
            "description": "Roundview Capital LLC reduced its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 52.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 8,481 shares of the healthcare product maker\u2019s stock after selling 9,269 s\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/roundview-capital-llc-has-925000-stock-position-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T14:54:42Z",
            "content": "Roundview Capital LLC reduced its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 52.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 8,481 shares o\u2026 [+6120 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Stock Position Lowered by First Western Trust Bank",
            "description": "First Western Trust Bank cut its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 73,353 shares of the healthca\u2026",
            "url": "https://www.etfdailynews.com/2023/11/20/abbott-laboratories-nyseabt-stock-position-lowered-by-first-western-trust-bank/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-20T18:48:46Z",
            "content": "First Western Trust Bank cut its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.9% during the second quarter, according to its most recent disclosure with the Securities &amp; E\u2026 [+6753 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Bought by Ally Financial Inc.",
            "description": "Ally Financial Inc. grew its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 111.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 19,000 shares of the healthcare product maker\u2019s stock after purchasing an additio\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/abbott-laboratories-nyseabt-shares-bought-by-ally-financial-inc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T18:52:54Z",
            "content": "Ally Financial Inc. grew its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 111.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 19,000 shares of the \u2026 [+6571 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Food Safety News"
            },
            "author": "News Desk",
            "title": "Similac probiotics product under recall after adverse reactions in preterm babies",
            "description": "Abbott Laboratories is recalling more than 226,000 packets of Similac brand Probiotic Tri-Blend baby food because of \u201cserious adverse reactions to product in preterm infants.\u201d The company initiated the recall on Oct. 31 and it is ongoing. It was just posted b\u2026",
            "url": "https://www.foodsafetynews.com/2023/11/similac-probiotics-product-under-recall-after-adverse-reactions-in-preterm-babies/",
            "urlToImage": "https://images.bannerbear.com/direct/y0aJ23zRDdqMxX4OGl/requests/000/044/788/972/XwJBnmPj46w8OxMXQvLqob2xG/731b9731d911cc1b3d1d346803caa39f47bb849d.png",
            "publishedAt": "2023-11-09T00:30:00Z",
            "content": "Abbott Laboratories is recalling more than 226,000 packets of Similac brand Probiotic Tri-Blend baby food because of serious adverse reactions to product in preterm infants.\r\nThe company initiated th\u2026 [+1165 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Burney Co. Sells 1,765 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Burney Co. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 31,377 shares of the healthcare product make\u2026",
            "url": "https://www.etfdailynews.com/2023/11/15/burney-co-sells-1765-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-15T21:04:42Z",
            "content": "Burney Co. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC.\u2026 [+5708 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Sold by Hamel Associates Inc.",
            "description": "Hamel Associates Inc. lowered its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 18.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 19,008 shares of th\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/abbott-laboratories-nyseabt-shares-sold-by-hamel-associates-inc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T22:48:41Z",
            "content": "Hamel Associates Inc. lowered its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 18.5% during the second quarter, according to the company in its most recent disclosure with the Securiti\u2026 [+6848 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Machina Capital S.A.S. Sells 1,844 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Machina Capital S.A.S. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 26.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,067 shares of th\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/machina-capital-s-a-s-sells-1844-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T16:40:45Z",
            "content": "Machina Capital S.A.S. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 26.7% during the 2nd quarter, according to its most recent disclosure with the Securities and \u2026 [+6701 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Kelleher Financial Advisors Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Kelleher Financial Advisors boosted its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 19.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional \u2026",
            "url": "https://www.etfdailynews.com/2023/11/17/kelleher-financial-advisors-boosts-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-17T15:24:52Z",
            "content": "Kelleher Financial Advisors boosted its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 19.6% in the 2nd quarter, according to the company in its most recent Form 13F filing wit\u2026 [+6537 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "GSB Wealth Management LLC Increases Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "GSB Wealth Management LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,053 sha\u2026",
            "url": "https://www.etfdailynews.com/2023/11/07/gsb-wealth-management-llc-increases-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-07T15:28:53Z",
            "content": "GSB Wealth Management LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.6% in the second quarter, according to the company in its most recent filing with the S\u2026 [+6490 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Hoylecohen LLC Buys 193 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Hoylecohen LLC increased its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7\u2026",
            "url": "https://www.etfdailynews.com/2023/11/05/hoylecohen-llc-buys-193-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-05T18:28:41Z",
            "content": "Hoylecohen LLC increased its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and E\u2026 [+7443 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Ieq Capital LLC Grows Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Ieq Capital LLC raised its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 98,183 shares of the healthcare pro\u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/ieq-capital-llc-grows-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T18:00:47Z",
            "content": "Ieq Capital LLC raised its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The inst\u2026 [+6666 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Holdings Raised by Guggenheim Capital LLC",
            "description": "Guggenheim Capital LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 26.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor \u2026",
            "url": "https://www.etfdailynews.com/2023/11/23/abbott-laboratories-nyseabt-holdings-raised-by-guggenheim-capital-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-23T16:10:44Z",
            "content": "Guggenheim Capital LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 26.9% during the second quarter, according to the company in its most recent disclosure with the S\u2026 [+5608 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Bought by RBO & Co. LLC",
            "description": "RBO & Co. LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 224,390 shares of the healthcare produ\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/abbott-laboratories-nyseabt-shares-bought-by-rbo-co-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T17:14:59Z",
            "content": "RBO &amp; Co. LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange C\u2026 [+6625 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Pinebridge Investments L.P. Sells 432,832 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Pinebridge Investments L.P. reduced its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 69.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 190,790 shares of the h\u2026",
            "url": "https://www.etfdailynews.com/2023/11/30/pinebridge-investments-l-p-sells-432832-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-30T20:02:43Z",
            "content": "Pinebridge Investments L.P. reduced its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 69.4% in the second quarter, according to the company in its most recent Form 13F filing with the S\u2026 [+6713 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Stock Holdings Lessened by Heritage Trust Co",
            "description": "Heritage Trust Co lessened its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.7% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 61,662 shares of the \u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/abbott-laboratories-nyseabt-stock-holdings-lessened-by-heritage-trust-co/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T19:10:46Z",
            "content": "Heritage Trust Co lessened its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.7% in the second quarter, according to the company in its most recent filing with the Securities\u2026 [+6666 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Sold by Concentric Wealth Management LLC",
            "description": "Concentric Wealth Management LLC lowered its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.4% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,935 shares of the healthcare product \u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/abbott-laboratories-nyseabt-shares-sold-by-concentric-wealth-management-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T15:31:18Z",
            "content": "Concentric Wealth Management LLC lowered its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.4% in the second quarter, according to its most recent disclosure with the SEC. The institut\u2026 [+6592 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Shelton Capital Management Sells 6,648 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Shelton Capital Management trimmed its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 47,048 shares of the healthcare product m\u2026",
            "url": "https://www.etfdailynews.com/2023/11/18/shelton-capital-management-sells-6648-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-18T21:08:43Z",
            "content": "Shelton Capital Management trimmed its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the S\u2026 [+6096 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Acquired by Capital International Inc. CA",
            "description": "Capital International Inc. CA increased its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 342,668 shares of the healthcare product maker\u2019s stock after\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/abbott-laboratories-nyseabt-shares-acquired-by-capital-international-inc-ca/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T22:50:41Z",
            "content": "Capital International Inc. CA increased its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned \u2026 [+6792 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Sei Investments Co. Sells 40,849 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Sei Investments Co. reduced its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 773,553 shar\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/sei-investments-co-sells-40849-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T21:24:42Z",
            "content": "Sei Investments Co. reduced its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchan\u2026 [+6755 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Investment Partners LTD. Reduces Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Investment Partners LTD. lessened its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 3.4% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,532 shares of the hea\u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/investment-partners-ltd-reduces-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T22:44:45Z",
            "content": "Investment Partners LTD. lessened its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 3.4% in the second quarter, according to the company in its most recent 13F filing with the Securities &\u2026 [+7209 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Sold by Spire Wealth Management",
            "description": "Spire Wealth Management lessened its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,153 s\u2026",
            "url": "https://www.etfdailynews.com/2023/11/14/abbott-laboratories-nyseabt-shares-sold-by-spire-wealth-management/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-14T14:34:45Z",
            "content": "Spire Wealth Management lessened its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.8% in the second quarter, according to the company in its most recent Form 13F filing with the Secur\u2026 [+5574 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Purchased by AdvisorShares Investments LLC",
            "description": "AdvisorShares Investments LLC grew its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 32.5% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor ow\u2026",
            "url": "https://www.etfdailynews.com/2023/11/12/abbott-laboratories-nyseabt-shares-purchased-by-advisorshares-investments-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-12T20:00:41Z",
            "content": "AdvisorShares Investments LLC grew its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 32.5% during the second quarter, according to its most recent Form 13F filing with the Sec\u2026 [+5992 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "XML Financial LLC Buys 686 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "XML Financial LLC raised its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 33,356 shares of the healthca\u2026",
            "url": "https://www.etfdailynews.com/2023/11/05/xml-financial-llc-buys-686-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-05T17:18:42Z",
            "content": "XML Financial LLC raised its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.1% in the 2nd quarter, according to the company in its most recent filing with the Securities &amp; E\u2026 [+7071 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Arrow Financial Corp Raises Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "Arrow Financial Corp boosted its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor own\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/arrow-financial-corp-raises-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T18:52:44Z",
            "content": "Arrow Financial Corp boosted its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities a\u2026 [+6824 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Heritage Wealth Advisors Reduces Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Heritage Wealth Advisors lessened its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,701 sha\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/heritage-wealth-advisors-reduces-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T17:41:20Z",
            "content": "Heritage Wealth Advisors lessened its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange C\u2026 [+6501 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Montag A & Associates Inc. Boosts Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Montag A & Associates Inc. grew its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 8.4% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 115,492 shares of the h\u2026",
            "url": "https://www.etfdailynews.com/2023/11/12/montag-a-associates-inc-boosts-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-12T19:24:41Z",
            "content": "Montag A &amp; Associates Inc. grew its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 8.4% during the second quarter, according to its most recent disclosure with the Securiti\u2026 [+6187 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Glassman Wealth Services Boosts Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Glassman Wealth Services grew its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 17.7% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,722 shares of the healthcare pr\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/glassman-wealth-services-boosts-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T16:40:49Z",
            "content": "Glassman Wealth Services grew its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 17.7% in the 2nd quarter, according to the company in its most recent filing with the Securities &amp; Excha\u2026 [+6266 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Lcnb Corp Grows Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Lcnb Corp grew its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,952 shares of the healthcare \u2026",
            "url": "https://www.etfdailynews.com/2023/12/03/lcnb-corp-grows-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-03T16:50:48Z",
            "content": "Lcnb Corp grew its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities &amp; Exch\u2026 [+6710 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Investor's Business Daily"
            },
            "author": "Investor's Business Daily",
            "title": "Novo Nordisk Stock Skids \u2014 But These Weight-Loss Results Are 'Hard To Ignore'",
            "description": "Patients who took Wegovy for five years had a 70% reduced risk of developing diabetes.",
            "url": "https://www.investors.com/news/technology/novo-nordisk-stock-can-weight-loss-drugs-prevent-diabetes/",
            "urlToImage": "https://www.investors.com/wp-content/uploads/2020/10/Stock-EliLilly-Lab01-company.jpg",
            "publishedAt": "2023-11-13T16:25:07Z",
            "content": "Novo Nordisk (NVO) stock slumped Monday even though the company unveiled promising test results that suggest a new class of weight-loss drugs could prevent some patients from developing diabetes.\r\nXT\u2026 [+3682 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Stake Lifted by UNIVEST FINANCIAL Corp",
            "description": "UNIVEST FINANCIAL Corp increased its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,054 shar\u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/abbott-laboratories-nyseabt-stake-lifted-by-univest-financial-corp/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T18:38:46Z",
            "content": "UNIVEST FINANCIAL Corp increased its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Co\u2026 [+7680 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Prospera Financial Services Inc Raises Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "Prospera Financial Services Inc boosted its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 88,374 sha\u2026",
            "url": "https://www.etfdailynews.com/2023/11/07/prospera-financial-services-inc-raises-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-07T22:08:41Z",
            "content": "Prospera Financial Services Inc boosted its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.1% during the second quarter, according to the company in its most recent disclosure with the\u2026 [+6497 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Purchased by Ellevest Inc.",
            "description": "Ellevest Inc. increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,355 shares of the healthcare p\u2026",
            "url": "https://www.etfdailynews.com/2023/11/12/abbott-laboratories-nyseabt-shares-purchased-by-ellevest-inc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-12T19:24:41Z",
            "content": "Ellevest Inc. increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange\u2026 [+6254 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "GraniteShares Advisors LLC Sells 229 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "GraniteShares Advisors LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,978 shar\u2026",
            "url": "https://www.etfdailynews.com/2023/11/15/graniteshares-advisors-llc-sells-229-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-15T21:40:42Z",
            "content": "GraniteShares Advisors LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.4% in the 2nd quarter, according to the company in its most recent 13F filing with the\u2026 [+6322 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Holistic Financial Partners Has $240,000 Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Holistic Financial Partners boosted its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 8.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,199 shares\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/holistic-financial-partners-has-240000-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T20:10:45Z",
            "content": "Holistic Financial Partners boosted its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 8.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the S\u2026 [+5972 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Sold by Equitable Trust Co.",
            "description": "Equitable Trust Co. trimmed its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 26,475 shares of the hea\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/abbott-laboratories-nyseabt-shares-sold-by-equitable-trust-co/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T19:36:43Z",
            "content": "Equitable Trust Co. trimmed its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.3% during the second quarter, according to the company in its most recent filing with the Securities and \u2026 [+5845 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Archer Investment Corp Cuts Stock Position in Abbott Laboratories (NYSE:ABT)",
            "description": "Archer Investment Corp lessened its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 15.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,498 shares of the healthc\u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/archer-investment-corp-cuts-stock-position-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T14:52:54Z",
            "content": "Archer Investment Corp lessened its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 15.5% during the 2nd quarter, according to its most recent filing with the Securities and Exc\u2026 [+6027 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Holdings Trimmed by Franklin Resources Inc.",
            "description": "Franklin Resources Inc. lowered its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,050,999 sh\u2026",
            "url": "https://www.etfdailynews.com/2023/11/23/abbott-laboratories-nyseabt-holdings-trimmed-by-franklin-resources-inc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-23T19:26:42Z",
            "content": "Franklin Resources Inc. lowered its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.0% in the 2nd quarter, according to its most recent disclosure with the Securities &amp; Ex\u2026 [+6259 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Fiera Capital Corp Trims Stock Position in Abbott Laboratories (NYSE:ABT)",
            "description": "Fiera Capital Corp trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 24.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned \u2026",
            "url": "https://www.etfdailynews.com/2023/11/16/fiera-capital-corp-trims-stock-position-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-16T14:30:46Z",
            "content": "Fiera Capital Corp trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 24.1% in the second quarter, according to the company in its most recent filing with the Securitie\u2026 [+5733 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Sold by Gabelli Funds LLC",
            "description": "Gabelli Funds LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 68,300 shares of th\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/abbott-laboratories-nyseabt-shares-sold-by-gabelli-funds-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T13:10:59Z",
            "content": "Gabelli Funds LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.8% during the second quarter, according to its most recent 13F filing with the Securities and E\u2026 [+6304 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Payden & Rygel Reduces Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Payden & Rygel cut its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 210,890 shares of the\u2026",
            "url": "https://www.etfdailynews.com/2023/11/19/payden-rygel-reduces-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-19T16:22:48Z",
            "content": "Payden &amp; Rygel cut its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and\u2026 [+6800 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Crawford Investment Counsel Inc. Decreases Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "Crawford Investment Counsel Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.1% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 24,525 shares of the healthcare\u2026",
            "url": "https://www.etfdailynews.com/2023/12/02/crawford-investment-counsel-inc-decreases-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-02T16:38:44Z",
            "content": "Crawford Investment Counsel Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.1% during the 2nd quarter, according to its most recent 13F filing with the SEC. The \u2026 [+6111 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Lbp Am Sa Purchases 37,236 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Lbp Am Sa increased its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 9.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 440,670 shares of the healthca\u2026",
            "url": "https://www.etfdailynews.com/2023/12/04/lbp-am-sa-purchases-37236-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-04T18:00:45Z",
            "content": "Lbp Am Sa increased its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 9.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Com\u2026 [+5731 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Cibc World Market Inc. Trims Stock Position in Abbott Laboratories (NYSE:ABT)",
            "description": "Cibc World Market Inc. trimmed its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 250,805 shares of the healthcare product maker\u2019s stock after selli\u2026",
            "url": "https://www.etfdailynews.com/2023/11/29/cibc-world-market-inc-trims-stock-position-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-29T21:22:41Z",
            "content": "Cibc World Market Inc. trimmed its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 6.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 250,80\u2026 [+5809 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Russell Investments Group Ltd. Has $98.86 Million Position in Abbott Laboratories (NYSE:ABT)",
            "description": "Russell Investments Group Ltd. decreased its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 14.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 906,985\u2026",
            "url": "https://www.etfdailynews.com/2023/11/17/russell-investments-group-ltd-has-98-86-million-position-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-17T21:04:50Z",
            "content": "Russell Investments Group Ltd. decreased its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 14.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchang\u2026 [+5787 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Cetera Advisor Networks LLC Has $19.59 Million Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "Cetera Advisor Networks LLC trimmed its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 3.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 179,712 sha\u2026",
            "url": "https://www.etfdailynews.com/2023/11/16/cetera-advisor-networks-llc-has-19-59-million-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-16T17:04:42Z",
            "content": "Cetera Advisor Networks LLC trimmed its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 3.0% in the second quarter, according to the company in its most recent Form 13F filing with the Se\u2026 [+5769 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Sold by Sheaff Brock Investment Advisors LLC",
            "description": "Sheaff Brock Investment Advisors LLC reduced its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional \u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/abbott-laboratories-nyseabt-shares-sold-by-sheaff-brock-investment-advisors-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T17:20:42Z",
            "content": "Sheaff Brock Investment Advisors LLC reduced its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.1% in the 2nd quarter, according to the company in its most recent 13F filing with the \u2026 [+6519 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Buys 72,812 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lifted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 9.5% during the second quarter, according to its most recent disclosure wi\u2026",
            "url": "https://www.etfdailynews.com/2023/11/11/united-super-pty-ltd-in-its-capacity-as-trustee-for-the-construction-building-unions-superannuation-fund-buys-72812-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-11T17:20:47Z",
            "content": "United Super Pty Ltd in its capacity as Trustee for the Construction &amp; Building Unions Superannuation Fund lifted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 9.5% durin\u2026 [+6337 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "William Blair Investment Management LLC Purchases 5,475 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "William Blair Investment Management LLC increased its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 100,192 shares of the healthc\u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/william-blair-investment-management-llc-purchases-5475-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T12:44:59Z",
            "content": "William Blair Investment Management LLC increased its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 5.8% during the second quarter, according to the company in its most recent 13F filin\u2026 [+6474 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Security Financial Services INC. Purchases 286 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Security Financial Services INC. lifted its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 7.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional inve\u2026",
            "url": "https://www.etfdailynews.com/2023/11/29/security-financial-services-inc-purchases-286-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-29T15:54:48Z",
            "content": "Security Financial Services INC. lifted its position in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 7.5% during the second quarter, according to its most recent disclosure with the Secu\u2026 [+5769 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Coastal Investment Advisors Inc. Buys 579 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Coastal Investment Advisors Inc. lifted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor o\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/coastal-investment-advisors-inc-buys-579-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T13:58:45Z",
            "content": "Coastal Investment Advisors Inc. lifted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 12.7% during the second quarter, according to its most recent filing with the Securities\u2026 [+6529 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Bought by Sirios Capital Management L P",
            "description": "Sirios Capital Management L P raised its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 17.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,3\u2026",
            "url": "https://www.etfdailynews.com/2023/12/01/abbott-laboratories-nyseabt-shares-bought-by-sirios-capital-management-l-p/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-01T18:26:59Z",
            "content": "Sirios Capital Management L P raised its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 17.9% during the second quarter, according to its most recent 13F filing with the Securities and Exch\u2026 [+6094 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Capasso Planning Partners LLC Buys 416 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Capasso Planning Partners LLC grew its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 10.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,365 shares of the healthc\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/capasso-planning-partners-llc-buys-416-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T19:20:41Z",
            "content": "Capasso Planning Partners LLC grew its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 10.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange \u2026 [+5852 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Private Advisor Group LLC Sells 3,118 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Private Advisor Group LLC trimmed its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 142,657 shares\u2026",
            "url": "https://www.etfdailynews.com/2023/11/16/private-advisor-group-llc-sells-3118-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-16T17:36:42Z",
            "content": "Private Advisor Group LLC trimmed its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Sec\u2026 [+6486 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Kestra Advisory Services LLC Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Kestra Advisory Services LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1\u2026",
            "url": "https://www.etfdailynews.com/2023/11/25/kestra-advisory-services-llc-boosts-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-25T16:51:02Z",
            "content": "Kestra Advisory Services LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 4.1% during the 2nd quarter, according to the company in its most recent Form 13F filing\u2026 [+5731 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Van Cleef Asset Management Inc Has $737,000 Position in Abbott Laboratories (NYSE:ABT)",
            "description": "Van Cleef Asset Management Inc cut its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 9.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,764 shares of the heal\u2026",
            "url": "https://www.etfdailynews.com/2023/12/04/van-cleef-asset-management-inc-has-737000-position-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-04T17:22:42Z",
            "content": "Van Cleef Asset Management Inc cut its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 9.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and \u2026 [+5747 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Column Capital Advisors LLC Buys 108,017 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Column Capital Advisors LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2,210.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 112,\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/column-capital-advisors-llc-buys-108017-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T22:48:41Z",
            "content": "Column Capital Advisors LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2,210.7% during the second quarter, according to the company in its most recent disclosure with\u2026 [+5839 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Charles Schwab Investment Management Inc. Sells 22,318 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Charles Schwab Investment Management Inc. lessened its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The insti\u2026",
            "url": "https://www.etfdailynews.com/2023/11/15/charles-schwab-investment-management-inc-sells-22318-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-15T20:30:43Z",
            "content": "Charles Schwab Investment Management Inc. lessened its holdings in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.2% during the second quarter, according to the company in its most recent Form 13F\u2026 [+5745 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Blue Bell Private Wealth Management LLC Purchases 300 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Blue Bell Private Wealth Management LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 175.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). Th\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/blue-bell-private-wealth-management-llc-purchases-300-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T16:06:50Z",
            "content": "Blue Bell Private Wealth Management LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 175.4% during the 2nd quarter, according to the company in its most recent \u2026 [+5731 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Epoch Investment Partners Inc. Reduces Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Epoch Investment Partners Inc. trimmed its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 61,721 shares of the healthcare product maker\u2019s stock\u2026",
            "url": "https://www.etfdailynews.com/2023/12/02/epoch-investment-partners-inc-reduces-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-02T18:00:46Z",
            "content": "Epoch Investment Partners Inc. trimmed its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund\u2026 [+5700 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Purchased by Legacy Capital Group California Inc.",
            "description": "Legacy Capital Group California Inc. raised its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,791\u2026",
            "url": "https://www.etfdailynews.com/2023/11/18/abbott-laboratories-nyseabt-shares-purchased-by-legacy-capital-group-california-inc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-18T22:24:42Z",
            "content": "Legacy Capital Group California Inc. raised its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities &\u2026 [+5741 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "9,580 Shares in Abbott Laboratories (NYSE:ABT) Acquired by Union Savings Bank",
            "description": "Union Savings Bank acquired a new position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 9,580 shares of the healthcare product maker\u2019s stock, valued \u2026",
            "url": "https://www.etfdailynews.com/2023/12/04/9580-shares-in-abbott-laboratories-nyseabt-acquired-by-union-savings-bank/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-04T16:38:44Z",
            "content": "Union Savings Bank acquired a new position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 9\u2026 [+6258 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Vantage Financial Partners Ltd. Inc. Takes $213,000 Position in Abbott Laboratories (NYSE:ABT)",
            "description": "Vantage Financial Partners Ltd. Inc. purchased a new stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,950\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/vantage-financial-partners-ltd-inc-takes-213000-position-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T17:39:05Z",
            "content": "Vantage Financial Partners Ltd. Inc. purchased a new stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) in the 2nd quarter, according to the company in its most recent disclosure with th\u2026 [+6450 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Capital Group Investment Management PTE. LTD. Lowers Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Capital Group Investment Management PTE. LTD. cut its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fir\u2026",
            "url": "https://www.etfdailynews.com/2023/11/22/capital-group-investment-management-pte-ltd-lowers-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-22T21:24:42Z",
            "content": "Capital Group Investment Management PTE. LTD. cut its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.5% in the 2nd quarter, according to the company in its most recent disclosur\u2026 [+6081 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Econ Financial Services Corp Acquires 3,760 Shares of Abbott Laboratories (NYSE:ABT)",
            "description": "Econ Financial Services Corp increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 24.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor own\u2026",
            "url": "https://www.etfdailynews.com/2023/11/09/econ-financial-services-corp-acquires-3760-shares-of-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-09T16:40:49Z",
            "content": "Econ Financial Services Corp increased its holdings in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 24.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securi\u2026 [+5929 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Providence Capital Advisors LLC Has $5.15 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Providence Capital Advisors LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutiona\u2026",
            "url": "https://www.etfdailynews.com/2023/11/19/providence-capital-advisors-llc-has-5-15-million-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-19T15:46:46Z",
            "content": "Providence Capital Advisors LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 0.4% in the second quarter, according to the company in its most recent filing with th\u2026 [+5991 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "German American Bancorp Inc. Has $7.95 Million Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "German American Bancorp Inc. grew its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 72,\u2026",
            "url": "https://www.etfdailynews.com/2023/11/30/german-american-bancorp-inc-has-7-95-million-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-30T17:04:51Z",
            "content": "German American Bancorp Inc. grew its stake in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.0% during the second quarter, according to the company in its most recent filing with the Securities a\u2026 [+6785 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Abbott Laboratories (NYSE:ABT) Shares Bought by Wilbanks Smith & Thomas Asset Management LLC",
            "description": "Wilbanks Smith & Thomas Asset Management LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.7% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 62,909 shares of the healthcare product m\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/abbott-laboratories-nyseabt-shares-bought-by-wilbanks-smith-thomas-asset-management-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T21:10:42Z",
            "content": "Wilbanks Smith &amp; Thomas Asset Management LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 2.7% during the 2nd quarter, according to its most recent filing with t\u2026 [+6782 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Great West Life Assurance Co. Can Cuts Stake in Abbott Laboratories (NYSE:ABT)",
            "description": "Great West Life Assurance Co. Can lowered its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.8% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,364,732 shares of the healthcare product maker\u2019s s\u2026",
            "url": "https://www.etfdailynews.com/2023/11/19/great-west-life-assurance-co-can-cuts-stake-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-19T19:00:41Z",
            "content": "Great West Life Assurance Co. Can lowered its stake in shares of Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.8% during the 2nd quarter, according to its most recent filing with the SEC. The fir\u2026 [+6491 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Penobscot Investment Management Company Inc. Has $5.32 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)",
            "description": "Penobscot Investment Management Company Inc. trimmed its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm ow\u2026",
            "url": "https://www.etfdailynews.com/2023/11/15/penobscot-investment-management-company-inc-has-5-32-million-stock-holdings-in-abbott-laboratories-nyseabt/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-15T16:16:42Z",
            "content": "Penobscot Investment Management Company Inc. trimmed its position in Abbott Laboratories (NYSE:ABT \u2013 Free Report) by 1.2% in the second quarter, according to the company in its most recent Form 13F f\u2026 [+6419 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Future Market Insights Global and Consulting Pvt. Ltd.",
            "title": "Antibiotic Drugs Market on Track to Reach US$ 64.9 Billion by 2033, Driven by 3.7% CAGR | Future Market Insights Inc.",
            "description": "An Increase in Surgical Site Infection and CAUTI are Expected to Propel the Antibiotic Drugs Market Growth. Leading Key players include in Pfizer, Sanofi SA, AbbVie Inc. (Allergan plc), Teva Pharmaceuticals, GlaxoSmithKline plc, Novartis AG, Abbott Laboratori\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/16/2781743/0/en/Antibiotic-Drugs-Market-on-Track-to-Reach-US-64-9-Billion-by-2033-Driven-by-3-7-CAGR-Future-Market-Insights-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa",
            "publishedAt": "2023-11-16T12:30:00Z",
            "content": "NEWARK, Del, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The antibiotic drugs market was valued at US$ 43.6 billion in 2022 and is expected to reach US$ 64.9 billion by 2033. The market is set to grow around 3\u2026 [+8521 chars]"
        }
    ]
}